{"id":68790,"date":"2026-02-22T07:34:38","date_gmt":"2026-02-22T07:34:38","guid":{"rendered":"https:\/\/medsbase.com\/?post_type=product&#038;p=68790"},"modified":"2026-10-15T10:34:00","modified_gmt":"2026-10-15T10:34:00","slug":"bpc-157-tb-500-blend","status":"publish","type":"product","link":"https:\/\/medsbase.com\/pt-pt\/product\/bpc-157-tb-500-blend\/","title":{"rendered":"Mistura BPC-157 + TB-500"},"content":{"rendered":"<p><!-- medsbase-related-alts-v1 --><\/p>\n<div class=\"medsbase-tldr-answer\" style=\"background: #fff8e1; border-left: 4px solid #f5a623; padding: 16px 22px; margin: 0 0 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 17px;\">Resposta R\u00e1pida \u2014 O que \u00e9 a Mistura BPC-157 + TB-500?<\/h3>\n<p style=\"margin: 0;\">This is a pre-mixed peptide supplied as a 50\/50 blend of BPC-157 and TB-500 (Thymosin Beta-4) in a single lyophilized vial. Three total-mg strengths are available: <strong>10 mg<\/strong> (5 mg BPC + 5 mg TB), <strong>20 mg<\/strong> (10 mg + 10 mg), e <strong>30 mg<\/strong> (15 mg + 15 mg) \u2014 each in pack sizes of 10, 20, or 30 vials. The pre-blend saves a reconstitution step for protocols that study these two compounds together.<\/p>\n<\/div>\n<div class=\"medsbase-trust-strip\" style=\"background: #f4f8fb; border: 1px solid #d8e3eb; padding: 12px 16px; margin: 16px 0; border-radius: 4px; font-size: 14px;\"><strong>O que obt\u00e9m com a MedsBase:<\/strong> Pharmaceutical-grade lyophilized peptides &middot; HPLC &ge;99% purity (COA on request) &middot; Discreet protective packaging &middot; Worldwide peptide courier &middot; 1,400+ verified <a href=\"https:\/\/medsbase.com\/pt-pt\/reviews\/\">de clientes<\/a><\/div>\n<h2>BPC-157 + TB-500 Blend \u2014 Pre-Mixed Dual-Peptide Compound<\/h2>\n<p>BPC-157 and TB-500 are the two most-studied peptides in the tissue-repair and systemic-recovery space. They target complementary pathways: BPC-157 (Body Protection Compound, a 15-amino-acid fragment derived from a gastric protein) is investigated for localized tissue repair, angiogenesis, and modulation of growth factors, while TB-500 (a synthetic fragment of Thymosin Beta-4) is studied for systemic cell migration, G-actin sequestration, and broader recovery signaling. Study protocols that investigate the two compounds together typically dose them in a 1:1 ratio, which is why a pre-mixed 50\/50 blend has become a standard supply format. This product eliminates the extra reconstitution step that would otherwise be required when running a combined-dosing study. <\/p>\n<h2>Porqu\u00ea uma Mistura em vez de Dois Frascos Separados?<\/h2>\n<p>Study labs running combined BPC-157 + TB-500 protocols have two supply choices: (a) order the peptides separately and reconstitute each vial independently, mixing the final doses at injection time, or (b) order a pre-blended vial and reconstitute once. Both approaches are valid. The blend is chosen most often when:<\/p>\n<ul>\n<li>The protocol is fixed at a 1:1 BPC:TB ratio across all study arms.<\/li>\n<li>O tempo de reconstitui\u00e7\u00e3o, o fardo da t\u00e9cnica est\u00e9ril e o invent\u00e1rio de frascos s\u00e3o centros de custo significativos.<\/li>\n<li>\u00c9 desejada uma propor\u00e7\u00e3o consistente de lote para lote (uma pr\u00e9-mistura \u00e9 fabricada segundo uma \u00fanica especifica\u00e7\u00e3o; frascos encomendados separadamente podem vir de lotes de produ\u00e7\u00e3o diferentes).<\/li>\n<\/ul>\n<p>Os compostos individuais permanecem dispon\u00edveis para protocolos que necessitam de titula\u00e7\u00e3o de dose independente de BPC-157 vs TB-500. Para mais informa\u00e7\u00f5es sobre os p\u00e9ptidos individuais, consulte o nosso <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> e <a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500-thymosin-beta-4-peptide-guide\/\">Guia sobre TB-500 (Timosina Beta-4)<\/a>. Para uma compara\u00e7\u00e3o direta entre os dois tratamentos, consulte o <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">Compara\u00e7\u00e3o entre BPC-157 e TB-500<\/a>. <\/p>\n<h2>Op\u00e7\u00f5es de For\u00e7a \u2014 Como Escolher<\/h2>\n<p>All three strengths contain the same 1:1 BPC-157: TB-500 ratio. The total-mg figure refers to the combined peptide mass per vial:<\/p>\n<ul>\n<li><strong>10 mg no total<\/strong> \u2014 5 mg BPC-157 + 5 mg TB-500 per vial. Suited to protocols studying lower dose ranges or short study durations. Best cost per vial; highest per-mg cost.<\/li>\n<li><strong>20 mg no total<\/strong> \u2014 10 mg BPC-157 + 10 mg TB-500 per vial. The most commonly ordered strength for multi-week protocols. Balanced on cost-per-mg and practical working-dilution volumes.<\/li>\n<li><strong>30 mg no total<\/strong> \u2014 15 mg BPC-157 + 15 mg TB-500 per vial. Best cost per mg; suited to longer studies or higher-dose arms.<\/li>\n<\/ul>\n<p>Est\u00e3o dispon\u00edveis embalagens de 10, 20 ou 30 frascos com pre\u00e7os escalonados \u2014 as embalagens de 20 e 30 frascos oferecem poupan\u00e7as significativas por frasco em compara\u00e7\u00e3o com o tamanho de entrada de 10 frascos. <\/p>\n<h2>Reconstitution \u2014 Standard Protocol<\/h2>\n<p>A mistura \u00e9 fornecida liofilizada. O m\u00e9todo de dilui\u00e7\u00e3o de trabalho \u00e9 o mesmo que para frascos de p\u00e9ptido \u00fanico:<\/p>\n<ol>\n<li>Reconstituir com \u00e1gua bacteriost\u00e1tica. Uma dilui\u00e7\u00e3o de trabalho comum para o frasco de 20 mg \u00e9 2 mL de <a href=\"https:\/\/medsbase.com\/pt-pt\/bac-water\/\">\u00c1gua BAC<\/a>, resultando em 10 mg\/mL de p\u00e9ptido total (5 mg\/mL de BPC + 5 mg\/mL de TB).<\/li>\n<li>Adicione a \u00e1gua bacteriost\u00e1tica suavemente pela parede interior do frasco \u2014 n\u00e3o jacte directamente sobre o p\u00f3 liofilizado.<\/li>\n<li>Agite suavemente durante 30\u201360 segundos at\u00e9 estar totalmente dissolvido. N\u00e3o agite vigorosamente; a agita\u00e7\u00e3o na interface ar-\u00e1gua pode fragmentar as estruturas dos p\u00e9ptidos.<\/li>\n<li>Identifique o frasco com a data de reconstitui\u00e7\u00e3o. Refrigere a 2\u20138 \u00b0C e utilize no prazo de 30 dias.<\/li>\n<\/ol>\n<p>Para um tratamento detalhado da matem\u00e1tica de dilui\u00e7\u00e3o e erros comuns de reconstitui\u00e7\u00e3o, consulte o nosso <a href=\"https:\/\/medsbase.com\/pt-pt\/bac-water-reconstitution-guide\/\">Guia de reconstitui\u00e7\u00e3o de BAC Water<\/a>. <\/p>\n<h2>Context \u2014 Combined BPC + TB Dosing<\/h2>\n<p>The rationale for studying BPC-157 and TB-500 together rests on their non-overlapping mechanisms. BPC-157 studies focuses on localized repair \u2014 angiogenesis, growth-factor modulation (FGF, VEGF, EGF), and tendon-to-bone attachment signaling. TB-500 studies targets systemic cell migration, G-actin binding, and broader inflammation-resolution pathways. In combination protocols, investigators hypothesize additive or even synergistic effects across the overlap zone between localized and systemic recovery. Typical reported protocol dose ranges (per peptide component):<\/p>\n<ul>\n<li>Componente BPC-157: 250\u2013500 \u00b5g por dose, uma ou duas vezes por dia, em ciclos de 4\u20138 semanas.<\/li>\n<li>Componente TB-500: 2\u20135 mg por semana, tipicamente divididos em 2\u20133 doses por semana.<\/li>\n<\/ul>\n<p>These figures reflect published studies protocols and are not prescribing recommendations. Neither BPC-157 nor TB-500 is approved for human therapeutic use by the FDA, EMA, MHRA, or TGA. Both are supplied as compounds for clinical investigation only. <\/p>\n<h2>Armazenamento &amp; Manipula\u00e7\u00e3o<\/h2>\n<ul>\n<li>Armazene os frascos liofilizados a 2\u20138 \u00b0C (frigor\u00edfico). Toleram-se breves per\u00edodos a temperatura ambiente durante o transporte.<\/li>\n<li>Ap\u00f3s reconstitui\u00e7\u00e3o, mantenha a solu\u00e7\u00e3o refrigerada e utilize-a no prazo de 30 dias.<\/li>\n<li>Evite ciclos repetidos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o.<\/li>\n<li>Proteja da luz direta. Frascos \u00e2mbar ou envolt\u00f3rio de folha s\u00e3o prefer\u00edveis para armazenamento refrigerado prolongado.<\/li>\n<li>Utilize \u00e1lcool isoprop\u00edlico a 70% para limpar a tampa de borracha antes de cada pun\u00e7\u00e3o com agulha.<\/li>\n<\/ul>\n<p class=\"medsbase-reship-line\" style=\"font-size: 14px; color: #444; margin: 8px 0 18px;\">\ud83d\udce6 Cada encomenda est\u00e1 coberta pela nossa <a href=\"https:\/\/medsbase.com\/pt-pt\/medsbase-re-shipment-assurance-policy\/\"><strong>Pol\u00edtica de Garantia de Reenvio<\/strong><\/a> \u2014 se a sua encomenda n\u00e3o chegar no prazo de 20 dias \u00fateis, reenviamo-la.<\/p>\n<table class=\"medsbase-spec-table\" style=\"width: 100%; border-collapse: collapse; margin: 18px 0; font-size: 14px;\">\n<thead>\n<tr style=\"background: #2c7cb0; color: #fff;\">\n<th style=\"padding: 8px 12px; text-align: left; width: 30%;\">Especifica\u00e7\u00e3o<\/th>\n<th style=\"padding: 8px 12px; text-align: left;\">Detalhe<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>N\u00famero CAS<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">composto (BPC-157 137525-51-0 \/ TB-500 77591-33-4)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>F\u00f3rmula Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: C<sub>62<\/sub>H<sub>98<\/sub>N<sub>16<\/sub>O<sub>22<\/sub> \u00b7 TB-500: C<sub>212<\/sub>H<sub>350<\/sub>N<sub>56<\/sub>O<sub>78<\/sub>S<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Peso Molecular<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157: 1419.55 Da \u00b7 TB-500: ~4963 Da<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Sequ\u00eancia<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">BPC-157 (15 aa) + Timosina \u03b2-4 acetilada (43 aa) co-liofilizada num \u00fanico frasco<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Forma<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">P\u00f3 liofilizado (ou conforme fornecido)<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Pureza<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u226599% (HPLC verificado, COA dispon\u00edvel mediante pedido)<\/td>\n<\/tr>\n<tr style=\"background: #f9f9f9;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Armazenamento<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">Mistura liofilizada: 2\u20138 \u00b0C (frigor\u00edfico) para estoque de trabalho; \u221220 \u00b0C para armazenamento a longo prazo de frascos n\u00e3o abertos. Reconstitu\u00eddo: 2\u20138 \u00b0C, utilizar dentro de ~30 dias. Evitar agita\u00e7\u00e3o vigorosa. N\u00e3o congelar-descongelar a solu\u00e7\u00e3o reconstitu\u00edda.<\/td>\n<\/tr>\n<tr style=\"background: #fff;\">\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0; width: 30%;\"><strong>Solubilidade<\/strong><\/td>\n<td style=\"padding: 8px 12px; border-bottom: 1px solid #e0e0e0;\">\u00c1gua bacteriost\u00e1tica (recomendada) ou \u00e1gua est\u00e9ril para per\u00edodos de utiliza\u00e7\u00e3o mais curtos<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Related Compounds<\/h2>\n<ul>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 guide<\/a> \u2014 o composto individual.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500-thymosin-beta-4-peptide-guide\/\">Guia sobre TB-500 (Timosina Beta-4)<\/a> \u2014 o composto individual.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">Compara\u00e7\u00e3o entre BPC-157 e TB-500<\/a> \u2014 tratamento direto cabe\u00e7a a cabe\u00e7a dos dois pept\u00eddeos.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/ghk-cu-copper-peptide-anti-aging-guide\/\">GHK-Cu (Copper Peptide) guide<\/a> \u2014 o composto de recupera\u00e7\u00e3o mais frequentemente empilhado com protocolos BPC\/TB.<\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/best-peptides-for-muscle-recovery\/\">Melhores pept\u00eddeos para pilha de recupera\u00e7\u00e3o muscular<\/a> \u2014 artigo central que cobre protocolos combinados.<\/li>\n<\/ul>\n<h2 id=\"faqs\">Perguntas Frequentes<\/h2>\n<h3>What is the BPC-157: TB-500 ratio in the blend?<\/h3>\n<p>As tr\u00eas concentra\u00e7\u00f5es s\u00e3o fornecidas numa propor\u00e7\u00e3o fixa de 1:1 em massa. O frasco de 10 mg cont\u00e9m 5 mg de BPC-157 + 5 mg de TB-500; o frasco de 20 mg cont\u00e9m 10 mg + 10 mg; o frasco de 30 mg cont\u00e9m 15 mg + 15 mg. <\/p>\n<h3>Por que escolher a mistura em vez de dois frascos separados?<\/h3>\n<p>A mistura poupa um passo de reconstitui\u00e7\u00e3o e garante uma propor\u00e7\u00e3o consistente de 1:1 durante o estudo. Frascos encomendados separadamente oferecem mais flexibilidade se pretender ajustar a dose dos dois compostos de forma independente. <\/p>\n<h3>Qual a dosagem que devo encomendar?<\/h3>\n<p>The 20 mg vial is the most commonly ordered strength for typical protocols. The 10 mg strength suits short studies or lower-dose arms. The 30 mg strength offers the best per-mg cost for longer studies or higher-dose arms. <\/p>\n<h3>Como deve ser reconstitu\u00edda a mistura?<\/h3>\n<p>Utilize \u00e1gua bacteriost\u00e1tica. Para o frasco de 20 mg, 2 mL de \u00e1gua bacteriost\u00e1tica proporcionam uma concentra\u00e7\u00e3o de trabalho de 10 mg\/mL de pept\u00eddeo total. Adicione a \u00e1gua suavemente pela lateral do frasco e agite \u2014 n\u00e3o agite vigorosamente. <\/p>\n<h3>Quanto tempo dura a mistura reconstitu\u00edda?<\/h3>\n<p>Refrigerada a 2\u20138 \u00b0C, deve ser utilizada no prazo de 30 dias. Evite ciclos repetidos de congela\u00e7\u00e3o-descongela\u00e7\u00e3o. Descarte se a solu\u00e7\u00e3o ficar turva ou mudar de cor. <\/p>\n<h3>What are the typical doses for this blend?<\/h3>\n<p>Published studies protocols typically dose 250\u2013500 \u00b5g of the BPC-157 component once or twice daily, and 2\u20135 mg of the TB-500 component weekly split across 2\u20133 doses. Because the ratio is fixed at 1:1, drawing a volume that delivers the target BPC-157 dose will simultaneously deliver the same mass of TB-500. <\/p>\n<h3>Esta mistura \u00e9 aprovada pela FDA?<\/h3>\n<p>No. Neither BPC-157 nor TB-500 is approved by the FDA, EMA, MHRA, TGA, or any other regulatory authority for human therapeutic use. This product is supplied strictly as a compound for clinical investigation. <\/p>\n<h3>A mistura pode ser armazenada \u00e0 temperatura ambiente?<\/h3>\n<p>Os frascos liofilizados n\u00e3o reconstitu\u00eddos s\u00e3o est\u00e1veis durante o transporte breve \u00e0 temperatura ambiente, mas devem ser refrigerados ap\u00f3s a chegada. Uma vez reconstitu\u00edda, a solu\u00e7\u00e3o deve ser refrigerada. <\/p>\n<h3>A embalagem de 20 mg dura mais tempo do que duas embalagens de 10 mg?<\/h3>\n<p>Por frasco, sim \u2014 o frasco de 20 mg cont\u00e9m o dobro do p\u00e9ptido por frasco. Ao n\u00edvel do kit, uma embalagem de 10 frascos com 20 mg de concentra\u00e7\u00e3o cont\u00e9m a mesma quantidade total de p\u00e9ptido (200 mg) que duas embalagens de 10 frascos com 10 mg de concentra\u00e7\u00e3o (tamb\u00e9m 200 mg), mas a um custo inferior por mg. <\/p>\n<h3>Qual \u00e9 o prazo de validade do frasco fechado?<\/h3>\n<p>Os p\u00e9ptidos liofilizados, quando armazenados corretamente a 2\u20138 \u00b0C, mant\u00eam-se est\u00e1veis at\u00e9 \u00e0 data de validade indicada pelo fabricante \u2014 normalmente 18\u201324 meses ap\u00f3s a produ\u00e7\u00e3o. Verifique sempre a data de validade no frasco individual. <\/p>\n<h3>Como \u00e9 que esta mistura se compara \u00e0 encomenda separada de BPC-157 e TB-500?<\/h3>\n<p>Funcionalmente equivalente se o seu protocolo seguir uma propor\u00e7\u00e3o de 1:1. A mistura poupa um passo de reconstitui\u00e7\u00e3o por lote e garante a consist\u00eancia da propor\u00e7\u00e3o. A abordagem com frascos separados \u00e9 prefer\u00edvel se pretender variar as doses dos dois p\u00e9ptidos de forma independente entre os grupos de estudo. <\/p>\n<h3>Enviam esta mistura internacionalmente?<\/h3>\n<p>Sim. Todas as encomendas apenas de p\u00e9ptidos s\u00e3o enviadas para todo o mundo atrav\u00e9s do nosso servi\u00e7o de mensagens dedicado a p\u00e9ptidos, sem custos adicionais. As encomendas mistas (p\u00e9ptidos mais outros medicamentos) utilizam o nosso servi\u00e7o padr\u00e3o de envio internacional com rastreio. <\/p>\n<h3>What is the recommended protocol for the BPC-157 + TB-500 blend?<\/h3>\n<p>Published preclinical studies using BPC-157 and TB-500 together employs each peptide at its individual protocol parameters \u2014 BPC-157 in the 250\u2013500 mcg range and TB-500 in the 2\u20135 mg range, with BPC-157 dosed more frequently due to its shorter half-life. Specific dosing for any application should be derived from peer-reviewed literature relevant to the study model. <\/p>\n<h3>Why does combining BPC-157 and TB-500 interest users?<\/h3>\n<p>BPC-157 and TB-500 target complementary tissue-repair pathways \u2014 BPC-157 primarily via VEGF, nitric oxide, and growth-hormone-receptor signalling with strong localised effects; TB-500 via actin binding, angiogenesis, and systemic distribution. Preclinical combination models have used both peptides together, and the two are frequently studied in the same repair and recovery contexts. <\/p>\n<h3>Qual o padr\u00e3o de pureza com que a MedsBase fornece esta mistura?<\/h3>\n<p>Todos os frascos desta mistura dispon\u00edveis na MedsBase s\u00e3o fornecidos com pureza HPLC de 99%+ em forma liofilizada. Um certificado de an\u00e1lise (COA) est\u00e1 dispon\u00edvel mediante pedido \u2014 contacte a nossa equipa de apoio ap\u00f3s efetuar a sua encomenda e enviaremos o COA espec\u00edfico do lote para os frascos que recebeu. <!-- medsbase-peptide-guide-cta --><\/p>\n<h2>Leitura Adicional<\/h2>\n<div style=\"background: #f4f8fb; border-left: 4px solid #2c7cb0; padding: 18px 22px; margin: 18px 0; border-radius: 4px;\">\n<p style=\"margin: 0 0 8px 0;\"><strong>\ud83d\udcd6 Learn the science behind this peptide<\/strong><\/p>\n<p style=\"margin: 0;\">Leia o nosso guia completo baseado em evid\u00eancias: <a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\"><strong>BPC-157 vs TB-500 \u2014 compara\u00e7\u00e3o direta e orienta\u00e7\u00e3o para protocolos combinados<\/strong><\/a>. Covers mechanism of action, published study data, typical dosing ranges, reconstitution protocols, stacking considerations, and safety\/contraindication notes.<\/p>\n<\/div>\n<p><!-- medsbase-peptide-cluster-footer --><\/p>\n<div style=\"background: #eef7ee; border-left: 4px solid #4caf50; padding: 16px 22px; margin: 24px 0; border-radius: 4px;\">\n<h3 style=\"margin-top: 0; font-size: 16px;\">Related Peptide Guides<\/h3>\n<ul style=\"margin: 8px 0 0 0;\">\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-peptide-healing-recovery-guide\/\">BPC-157 Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/tb-500-thymosin-beta-4-peptide-guide\/\">TB-500 (Thymosin Beta-4) Guide<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/bpc-157-vs-tb-500-comparison-guide\/\">BPC-157 vs TB-500 \u2014 Compara\u00e7\u00e3o Direta<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/best-peptides-for-muscle-recovery\/\">Melhores P\u00e9ptidos para Recupera\u00e7\u00e3o Muscular \u2014 Guia de Combina\u00e7\u00e3o<\/a><\/li>\n<li><a href=\"https:\/\/medsbase.com\/pt-pt\/peptides\/\">All Peptides at MedsBase<\/a><\/li>\n<\/ul>\n<\/div>\n<p><!-- \/medsbase-peptide-cluster-footer --><br \/>\n<!-- pep-seo-v1 --><\/p>","protected":false},"excerpt":{"rendered":"<p>\u2705 Suporta a sinaliza\u00e7\u00e3o celular<br \/>\n\u2705 Promove a modela\u00e7\u00e3o tecidular<br \/>\n\u2705 Enhances angiogenic activity<br data-is-only-node=\"\" \/>\u2705 Atividade fibrobl\u00e1stica observada<br \/>\n\u2705 Est\u00e1vel em ensaios experimentais<\/p>\n<p><strong>BPC-157 + TB-500<\/strong> cont\u00e9m composto de p\u00e9ptido sint\u00e9tico.<\/p>","protected":false},"featured_media":70988,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[5426],"product_tag":[5440,5448,5441,5442],"class_list":["post-68790","product","type-product","status-publish","has-post-thumbnail","product_cat-peptides","product_tag-bpc-157","product_tag-bpc-157-tb-500-blend","product_tag-peptide","product_tag-tb-500","first","instock","shipping-taxable","purchasable","product-type-variable","has-default-attributes"],"acf":[],"_links":{"self":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product\/68790","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/comments?post=68790"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media\/70988"}],"wp:attachment":[{"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/media?parent=68790"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_brand?post=68790"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_cat?post=68790"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/medsbase.com\/pt-pt\/wp-json\/wp\/v2\/product_tag?post=68790"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}